The bone marrow derived adult stem cells for dilated cardiomyopathy (REGENERATE-DCM) trial: Study design

Regenerative Medicine

Volumn 6, Issue 4, 2011, Pages 525-533

  Arnous, Samer ^a   Mozid, Abdul ^a   Mathur, Anthony ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

bone marrow; cardiac repair; dilated cardiomyopathy; heart failure; progenitor cell; randomized controlled trial; REGENERATE DCM trial; stem cell

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT STEM CELL; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; BONE MARROW DERIVED ADULT STEM CELL; CONGESTIVE CARDIOMYOPATHY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE DIMENSION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; HUMAN; INFUSION; LEUKOSTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEM CELL MOBILIZATION;

ADULT; ADULT STEM CELLS; ANIMALS; BONE MARROW CELLS; CARDIOMYOPATHY, DILATED; CLINICAL TRIALS AS TOPIC; ENDPOINT DETERMINATION; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; PLACEBOS; STEM CELL TRANSPLANTATION; TISSUE AND ORGAN HARVESTING;

EID: 79960205979     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.29     Document Type: Article

References (41)

1. Manolio TA, Baughman KL, Rodeheffer R, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am. J. Cardiol. 69(17), 1458-1466 (1992).
2. Hertz MI, Aurora P, Christie JD. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 Annual Reports. J. Heart Lung Transplant. 28, 989-992 (2009).
3. Codd MB, Sugrue DD, Gersh BJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 80, 564-572 (1989). (Pubitemid 19231390)
4. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 29(2), 270-276 (2008).
5. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur. Heart J. 23, 1867-1876 (2002). (Pubitemid 35398056)
6. Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107(9), 1278-1283 (2003). (Pubitemid 36314411)
7. Latini R, Masson S, Anand I, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur. Heart J. 25(4), 292-299 (2004). (Pubitemid 38295437)
8. Canetti M, Akhter M, Lerman A, et al. Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. Am. J. Cardiol. 92, 1246-1249 (2003). (Pubitemid 37377848)
9. Neglia D, Michelassi C, Trivieri M, Sambuceti G. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105, 186-193 (2002). (Pubitemid 34084317)
10. Taylor D, Edwards L, Boucek M, Trulock E, Keck B, Hertz M. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report -2004. J. Heart Lung Transplant. 23(7), 796-803 (2004). (Pubitemid 38953862)
11. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 410(6829), 701-705 (2001). (Pubitemid 32290358)
12. Yoon Y, Lee N, Scadova H. Myocardial regeneration with bone-marrow-derived stem cells. Biol. Cell 97(4), 253-263 (2005). (Pubitemid 40533084)
13. Abdel-Latif A, Bolli R, Tleyjeh I. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Int. Med. 167, 989-997 (2007). (Pubitemid 46835786)
14. Yeo C, Saunders N, Locca D, Flett A. Ficoll-Paque™ versus Lymphoprep™: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations. Regen. Med. 4(5), 689-696 (2009).
15. Thiess HD, David R, Engelmann M. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischemic cardiomyopathy (DCM and ICM). Eur. Heart J. 28, 1258-1264 (2007). (Pubitemid 47343832)
16. Li TS, Mikamo A, Takahashi M. Comparison of cell therapy and cytokine therapy for functional repair in ischemic and nonischemic heart failure. Cell Transplant. 16(4), 365-374 (2007).
17. Tomita S, Ishida M, Nakatani T, Fukuhara S, Hisashi Y, Ohtsu Y. Bone marrow is a source of regenerated cardiomyocytes in doxorubicin-induced cardiomyopathy and granulocyte colony-stimulating factor enhances migration of bone marrow cells and attenuates cardiotoxicity of doxorubicin under electron microscopy. J. Heart Lung Transplant. 23, 577-584 (2004). (Pubitemid 38595743)
18. Joseph J, Rimawi A, Mehta P, Cottler-Fox M, Sinha A. Safety and effectiveness of granulocyte-colony stimulating factor in mobilizing stem cells and improving cytokine profile in advanced chronic heart failure. Am. J. Cardiol. 97, 681-684 (2006). (Pubitemid 43255039)
19. Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88(3), 761-777 (1996). (Pubitemid 26333294)
20. Anderlini P, Donato M, Chan KW, et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 39(6), 555-560 (1999). (Pubitemid 29275323)
21. Bodine DM, Seidel NE, Gale MS, Nienhuis AW, Orlic D. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 84, 1482-1491 (1994). (Pubitemid 24273016)
22. Kurdi M, Booz G. G-CSF based stem cell therapy for the heart -unresolved issues part A: paracrine actions, mobilisation and delivery. Congest. Heart Fail. 13(4), 221-227 (2007).
23. Harada M, Qin Y, Takano H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11(3), 305-311 (2005). (Pubitemid 40460559)
24. Huttmann A, Duhrsen U, Stypmann J. Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure; feasability, safety and effects on exercise tolerance and cardiac function. Beasic Res. Cardiol. 101(1), 78-86 (2006). (Pubitemid 43323435)
25. Hoglund M, Smedmyr B, Bengtsson M, et al. Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers -a comparative study. Eur. J. Haematol. 59(3), 177-183 (1997). (Pubitemid 27392094)
26. Ings SJ, Balsa C, Leverett D, Mackinnon S, Linch DC, Watts MJ. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br. J. Haematol. 134(5), 517-525 (2006). (Pubitemid 44141718)
27. Abdel-Latif A, Bolli R, Zuba-Surma EK, Tleyjeh IM, Hornung CA, Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am. Heart J. 156(2), 216-226 (2008).
28. Kang H, Kim H, Zhang S, Park K, Cho H, Koo B. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet 363, 751-756 (2004). (Pubitemid 38315164)
29. Nagaya N, Kangawa K, Itoh T. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112, 1128-1135 (2005). (Pubitemid 41216119)
30. Wang X, Hu Q, Mansoor A, et al. Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts. Am. J. Physiol. Heart Circ. Physiol. 290(4), H1393-H1405 (2006).
31. Ghodsizad A, Ruhparwar A, Marktanner R. Autologous transplantation of CD133+ BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy. Cytotherapy 8, 308-310 (2006). (Pubitemid 43947796)
32. Arguero R, Careaga-Reyna G, Castano-Guerra R. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Arch. Med. Res. 37, 1010-1014 (2006). (Pubitemid 44512065)
33. Martino HF, Oliveira PS, Assuncao E. Cell therapy in dilated cardiomyopathy. Arquivos Brasileiros Cardiol. 86, 390-392 (2006). (Pubitemid 43854460)
34. Zeinaloo AA, Zanjani KS, Bagheri MM, Mohyeddin-Bonab M, Monajemzadeh M, Arjmandnia M. Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy. Pediatr. Transplantat. DOI: 10.1111/j.1399-3046.2010.01366.x (2010) (Epub ahead of print).
35. Kaparthi P, Namita G, Chelluri L. Autologous bone marrow mononuclear cell delivery to dilated cardiomyopathy patients: a clinical trial. Afr. J. Biotechnol. 7, 207-210 (2008). (Pubitemid 351239891)
36. Seth S, Narang R, Bhargava B. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: The first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J. Am. Coll. Cardiol. 48, 2350-2351 (2006). (Pubitemid 44855430)
37. Rupp S, Bauer J, Tonn T. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old-child with dilated cardiomyopathy. Pediatr. Transplant. 13, 620-623 (2009).
38. Fischer-Rasokat U, Assmus B, Seeger F. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitorcell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circulat. Heart Fail. 2, 417-423 (2009).
39. Vrtovec B, Poglajen G, Sever M. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J. Cardiac Fail. 17(4), 272-281 (2011).
40. Erbs S, Linke A, Schachinger V, Assmus B, Thiele H. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 116, 366-374 (2007). (Pubitemid 47196542)
41. Schannwell C, Kostering M, Zeus T, et al. Humane autologe Stammzelltransplantation zur Myokardregeneration bei dilatativer Kardiomyopathie (NYHA Stadium II bis III). J. Kardiol. 1-2, 23-30 (2008). (Pubitemid 351229582)